期刊文献+

显微镜下多血管炎肺损害20例临床分析 被引量:4

Clinical analysis of microscopic polyangiitis with pulmonary involvement in 20 cases
下载PDF
导出
摘要 目的 :研究显微镜下多血管炎(MPA)肺损害患者的临床特点。方法:对20例伴肺部损害的MPA患者临床资料进行回顾性分析,包括临床表现、实验室检查、肺部高分辨率CT(HRCT)、肺功能及病理活检。结果:20例肺部受累的MPA,常见肺部症状有咳嗽(占85%)、呼吸困难(占30%)、咳痰(占25%)和咯血(占20%)。95%(19/20)的患者血沉加快,55%(11/20)的患者C反应蛋白升高。90%(18/20)的患者抗髓过氧化物酶抗体(MPO-ANCA)阳性,5%(1/20)的患者抗蛋白酶3抗体(PR3-ANCA)阳性,5%(1/20)的患者MPO-ANCA、PR3-ANCA均阴性。肺部HRCT表现有磨玻璃影、肺间质纤维化、斑片浸润影、胸腔积液和支气管扩张。结论:MPA常累及肺部,可以肺部症状为首发临床表现,肺部受累的MPA临床表现及肺部HRCT影像学无明显特异性,及早予以ANCA检测及组织病理活检,以便早期诊治。 Objective: To analyze the clinical characters of pulmonary involvement in the patients with microscopic polyangiitis. Methods: Twenty cases of MPA with pulmonary involvement were analyzed retrospectively, including clinical manifestation, laboratory test results, chest high-resolution computed tomography, pulmonary function test and pathology. Results: The common symptoms were cough (85%), dyspnea (30%), expectoration (25%) and haemoptysis (20%). Erythrocyte sedimentation rate was elevated in 95% of MPA patients. C-reactive protein was elevated in 55%. The prevalence of positive MPO-ANCA antibodies in MPA patients was 90%, while PR3-ANCA was 5%. Chest HRCT manifestations consisted of ground-glass opacity, interstitial fibrosis, patchy infiltration, pleural effusion and bronchiectasis. Conclusions: The pulmonary is frequently involved in MPA. Pulmonary involvement is the initial manifestation. The chest radiographic and clinical manifestations are nonspecific. Serum ANCA and histopathologic biopsy can help to understand and diagnose MPA with pulmonary involvement early.
出处 《温州医学院学报》 CAS 2014年第3期219-221,共3页 Journal of Wenzhou Medical College
关键词 显微镜下多血管炎 肺损害 抗中性粒细胞胞浆抗体 HRCT microscopic polyangiitis pulmonary involvement anti-neutrophil cytoplasmic antibody high-resolution computed tomography
  • 相关文献

参考文献7

  • 1尹培达.显微镜下多血管炎诊治指南(草案)[J].中华风湿病学杂志,2004,8(9):564-566. 被引量:45
  • 2Chung SA, Seo P. Microscopic polyangiitis[J]. Rheum Dis Clin North Am, 2010, 36(3): 545-558.
  • 3West S, Arulkumaran N, Ind PW, et al. Diffuse alveolar haemorrhage in ANCA-associated vasculitis[J]. Intern Med, 2013, 52(1): 5-13.
  • 4Ando Y, Okada F, Matsumoto S, et al. Thoracic manifesta- tion of myeloperoxidase-antineutrophil cytoplasmic anti- body (MPO-ANCA)-related disease: CT findings in 51 patients[J]. J Comput Assist Tomogr, 2004, 28(5): 710- 716.
  • 5强军,高万勤,余卫,宋海乔,赵可,李云东,董少卿.显微镜下多血管炎肺损害的临床与CT表现[J].中华放射学杂志,2009,43(10):1052-1055. 被引量:13
  • 6Tzelepis GE, Kokosi M, Tzioufas A, et al. Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis [J]. Eur Respir J, 2010, 36(1): 116-121.
  • 7Kim JJ, Park JK, Wang YP, et al. Diffuse alveolar hemor- rhage in a 39-year-old woman: unusual initial presentation of microscopic polyangiitis[J]. Korean J Thorac Cardiovas Surg, 2011, 44(6): 448-451.

二级参考文献10

共引文献53

同被引文献28

  • 1张秀琴,胡朝军.480例血管炎PR3、MPO的阳性率观察[J].现代诊断与治疗,2012,23(12):2195-2196. 被引量:7
  • 2尹培达.显微镜下多血管炎诊治指南(草案)[J].中华风湿病学杂志,2004,8(9):564-566. 被引量:45
  • 3Galesic K,Ljubanovic D,Horvatic I.Treatment of renal manifestations of ANCA-associated vasculitis[J].J Nephropathol,2013,2(1):6-19.
  • 4Frankel S K,Cosgrove G P,Fischer A,et al.Update in the diagnosis and management of pulmonary vasculitis[J].Chest,2006,129(2):452-465.
  • 5Belaconi I N,Toma C L,Bogdan M A.Uptodate in the management and treatment of ANCA-associated vasculitis[J].Pneumologia,2014,63(2):78-80,83-76.
  • 6Chang W M,Dakanali M,Capule C C,et al.ANCA:A Family of Fluorescent Probes that Bind and Stain Amyloid Plaques in Human Tissue[J].ACS Chem Neurosci,2011,2(5):249-255.
  • 7Charles J J,Xiao H,Hu P.Complement in ANCA-associated vasculitis[J].Seminars in nephrology,2013,33(6):557-564.
  • 8Jennette J C,Falk R J,Andrassy K,et al.Nomenclature of systemic vasculitides.Proposal of an international consensus conference[J].Arthritis Rheum,1994,37(2):187-192.
  • 9Luqmani R A,Bacon P A,Moots R J,et al.Birmingham Vasculitis Activity Score(BVAS)in systemic necrotizing vasculitis[J].QJM,1994,87(11):671-678.
  • 10Jethava A,Ali S.Ischemic stroke as a presenting feature of Wegener’s granulomatosis[J].Conn Med,2013,77(9):533-535.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部